Key result
Elevated heart-type fatty acid-binding protein (highest vs lowest quartile) strongly predicted 1-year all-cause mortality in patients with acute coronary syndrome.
Why the study?
Because heart-type fatty acid-binding protein is released following myocardial ischemia and necrosis, its role in predicting all-cause mortality after acute coronary syndrome needed to be determined.
Does heart-type fatty acid-binding protein (H-FABP) level predict 1-year all-cause mortality in patients admitted with acute coronary syndrome?
Observational (n=1,448)
Does heart-type fatty acid-binding protein (H-FABP) level predict 1-year all-cause mortality in patients admitted with acute coronary syndrome?
Answers are grounded in this paper and cite their sources.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“The H-FABP test is a major advance on what we had before. It appears to be able to detect milder and earlier degrees of heart injury than do current tests which detect heart cell death.”
“This new blood test would appear to be able to more accurately identify patients with heart damage at an earlier course of their illness. If further research confirms its superiority over current tests, it has the potential to improve diagnosis and identify those people who require intensive investigation and treatment to prevent further problems.”
H-FABP measured 12-24 hours after symptom onset strongly predicts 1-year all-cause mortality in ACS patients, providing additive prognostic value to GRACE risk factors, troponin, and hs-CRP.
OBJECTIVES: Our aim was to determine if a high-performance assay for heart-type fatty acid-binding protein (H-FABP) has a role in predicting all-cause mortality after acute coronary syndrome (ACS). BACKGROUND: Heart-type fatty acid-binding protein is released into the circulation following myocardial ischemia and necrosis and therefore may be of value to physicians when caring for patients admitted to hospital with a clinical diagnosis of ACS. METHODS: This was a prospective observational study with a follow-up of 12 months. The H-FABP was measured 12 to 24 h after onset of symptoms in 1,448 patients admitted to hospital with ACS. The main outcome measure was all-cause mortality 1 year after index hospital admission. Multivariable analyses were conducted using the well validated GRACE (Global Registry of Acute Coronary Events) variables together with troponin I and highly sensitive C-reactive protein (hs-CRP). RESULTS: After 12 months of follow-up, 296 patients had died. Multivariable analysis demonstrated that H-FABP quartiles were strongly predictive of outcome: Q1 hazard ratio (HR) 1.0; Q2 HR 2.32 (95% confidence interval [CI] 1.25 to 4.30; p = 0.007); Q3 HR 3.17 (95% CI 1.73 to 5.82; p < 0.001); Q4 HR 4.88 (95% CI 2.67 to 8.93; p < 0.001). The crude all-cause 1-year mortality for unstable angina patients with H-FABP <5.8 microg/l was 2.1% compared with 22.9% for patients above this cutoff. The adjusted all-cause mortality HR in this group was 11.35 (95% CI 2.00 to 64.34; p = 0.006). CONCLUSIONS: Heart-type fatty acid-binding protein predicts long-term mortality after ACS and identifies high-risk patients in a manner that is additive to the GRACE clinical risk factors, troponin, and hs-CRP, possibly as a result of identifying the occurrence of myocardial ischemia with or without necrosis.
No takes yet. Share an insight, caveat, or question.
Kilcullen et al. (2007) conducted an observational in Acute Coronary Syndrome (n=1,448). Heart-type fatty acid-binding protein (H-FABP) vs. Lowest H-FABP quartile (Q1) was evaluated on All-cause mortality at 1 year (HR 4.88, 95% CI 2.67-8.93, p=<0.001). Elevated heart-type fatty acid-binding protein (highest vs lowest quartile) strongly predicted 1-year all-cause mortality in patients with acute coronary syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: